Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.

A J Zametkin1, S D Hamburger

  • 1Child Psychiatry Branch, NIMH, Bethesda, MD 10892.

Biological Psychiatry
|February 15, 1988
PubMed
Summary

Methylphenidate hydrochloride did not significantly alter urinary MHPG excretion in children with attention deficit hyperactivity disorder. No link was found between behavioral changes and urinary catecholamines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suicide in teenagers: assessment, management, and prevention.

JAMA·2002
Same author

Differentiating childhood-onset schizophrenia from psychotic mood disorders.

Journal of the American Academy of Child and Adolescent Psychiatry·2001
Same author

Aggression and psychiatric comorbidity in children with hypothalamic hamartomas and their unaffected siblings.

Journal of the American Academy of Child and Adolescent Psychiatry·2001
Same author

Case study: sexual hyperactivity treated with psychostimulants in familial male precocious puberty.

Journal of the American Academy of Child and Adolescent Psychiatry·2001
Same author

Abnormal neurologic maturation in adolescents with early-onset schizophrenia.

The American journal of psychiatry·2001
Same author

An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations.

Journal of the American Academy of Child and Adolescent Psychiatry·2000

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pediatrics

Background:

  • Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder.
  • Methylphenidate hydrochloride is a widely prescribed stimulant medication for ADHD.
  • Previous research suggests differential effects of stimulant medications on catecholamine metabolism.

Purpose of the Study:

  • To investigate the effect of methylphenidate hydrochloride on urinary catecholamine excretion in children with ADHD.
  • To compare methylphenidate's impact on 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion with findings from dextroamphetamine studies.
  • To explore potential relationships between behavioral changes and urinary catecholamine metabolites.

Main Methods:

  • An open-label trial involving children diagnosed with ADHD.

Related Experiment Videos

  • Administration of methylphenidate hydrochloride at a dosage of 0.74 +/- 0.2 mg/kg/day for two weeks.
  • Measurement of urinary catecholamines and their metabolites, including MHPG.
  • Behavioral assessments were conducted concurrently.

    • Main Results:

    • Methylphenidate hydrochloride treatment did not result in a significant change in urinary MHPG excretion.
    • The findings confirmed previous research indicating methylphenidate's lack of significant effect on MHPG levels.
    • No statistically significant correlation was observed between observed behavioral improvements and the measured urinary catecholamines or metabolites.

    Conclusions:

    • Methylphenidate hydrochloride does not appear to significantly alter MHPG excretion in pediatric ADHD patients.
    • The study supports the distinction between methylphenidate and dextroamphetamine regarding their effects on MHPG metabolism.
    • Behavioral changes in ADHD patients treated with methylphenidate are not directly correlated with the measured urinary catecholamine levels in this trial.